» Articles » PMID: 23555761

PPARβ/δ Regulates Glucocorticoid- and Sepsis-induced FOXO1 Activation and Muscle Wasting

Overview
Journal PLoS One
Date 2013 Apr 5
PMID 23555761
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

FOXO1 is involved in glucocorticoid- and sepsis-induced muscle wasting, in part reflecting regulation of atrogin-1 and MuRF1. Mechanisms influencing FOXO1 expression in muscle wasting are poorly understood. We hypothesized that the transcription factor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) upregulates muscle FOXO1 expression and activity with a downstream upregulation of atrogin-1 and MuRF1 expression during sepsis and glucocorticoid treatment and that inhibition of PPARβ/δ activity can prevent muscle wasting. We found that activation of PPARβ/δ in cultured myotubes increased FOXO1 activity, atrogin-1 and MuRF1 expression, protein degradation and myotube atrophy. Treatment of myotubes with dexamethasone increased PPARβ/δ expression and activity. Dexamethasone-induced FOXO1 activation and atrogin-1 and MuRF1 expression, protein degradation, and myotube atrophy were inhibited by PPARβ/δ blocker or siRNA. Importantly, muscle wasting induced in rats by dexamethasone or sepsis was prevented by treatment with a PPARβ/δ inhibitor. The present results suggest that PPARβ/δ regulates FOXO1 activation in glucocorticoid- and sepsis-induced muscle wasting and that treatment with a PPARβ/δ inhibitor may ameliorate loss of muscle mass in these conditions.

Citing Articles

Feedback loop centered on MAF1 reduces blood-brain barrier damage in sepsis-associated encephalopathy.

Wei X, Jiang W, Wang Z, Li Y, Jing Y, Han Y Cell Mol Biol Lett. 2025; 30(1):8.

PMID: 39833662 PMC: 11744841. DOI: 10.1186/s11658-025-00686-x.


Acute Sarcopenia: Mechanisms and Management.

Damanti S, Senini E, De Lorenzo R, Merolla A, Santoro S, Festorazzi C Nutrients. 2024; 16(20).

PMID: 39458423 PMC: 11510680. DOI: 10.3390/nu16203428.


Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19.

Badenes Bonet D, Caguana Velez O, Duran Jorda X, Comas Serrano M, Posso Rivera M, Admetllo M J Clin Med. 2023; 12(12).

PMID: 37373850 PMC: 10299438. DOI: 10.3390/jcm12124158.


Oligonucleotide Therapeutics for Age-Related Musculoskeletal Disorders: Successes and Challenges.

Nicholson T, Sagmeister M, Wijesinghe S, Farah H, Hardy R, Jones S Pharmaceutics. 2023; 15(1).

PMID: 36678864 PMC: 9866666. DOI: 10.3390/pharmaceutics15010237.


The Effects of COVID-19 on Skeletal Muscles, Muscle Fatigue and Rehabilitation Programs Outcomes.

Pescaru C, Maritescu A, Costin E, Traila D, Marc M, Trusculescu A Medicina (Kaunas). 2022; 58(9).

PMID: 36143878 PMC: 9500689. DOI: 10.3390/medicina58091199.


References
1.
Fosslien E . Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci. 2001; 31(1):25-67. View

2.
Escher P, Braissant O, Michalik L, Wahli W, Desvergne B . Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology. 2001; 142(10):4195-202. DOI: 10.1210/endo.142.10.8458. View

3.
Sanchez-Siles A, Ishimura N, Rumi M, Tamagawa Y, Ito S, Ishihara S . Administration of PPARβ/δ agonist reduces copper-induced liver damage in mice: possible implications in clinical practice. J Clin Biochem Nutr. 2011; 49(1):42-9. PMC: 3128365. DOI: 10.3164/jcbn.10-139. View

4.
Wang X, Song Z, Jiao H, Lin H . Dexamethasone facilitates lipid accumulation in chicken skeletal muscle. Stress. 2011; 15(4):443-56. DOI: 10.3109/10253890.2011.639413. View

5.
Alamdari N, Smith I, Aversa Z, Hasselgren P . Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2010; 299(2):R509-20. PMC: 2928620. DOI: 10.1152/ajpregu.00858.2009. View